5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine
ADVERTISEMENT
- Molecular formula
- C11H10BrN5
- CAS Number
- 98663-85-1
- IUPAC Name
- 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine
- Molecular Weight
- 294.14g/mol
- Melting Point
- (Celsius)
- Boiling Point
- (Celsius)
- Density
- 1.5400g/cm3
- Synonyms
- brimonidine
Identification
Interesting facts
Interesting Facts about 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine
This intriguing compound belongs to the class of quinoxaline derivatives, which have garnered significant attention in the field of medicinal chemistry due to their diverse biological activities. Here are some fascinating aspects of 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine:
- Bioactive Potential: Compounds like this one have been studied for their potential as anti-cancer agents. Their ability to interact with biological pathways makes them of great interest for drug design.
- Electrophilic Nature: The presence of the bromine atom suggests heightened electrophilic properties, which can enhance the compound's reactivity in various chemical transformations.
- Imidazole Motif: The inclusion of a dihydroimidazole group contributes to the overall stability and solubility, which is critical in optimizing the pharmacokinetic properties of potential drug candidates.
- Versatile Synthesis: This compound can be synthesized through various methods, including multi-step reactions that are commonly employed in medicinal chemistry, showcasing the creativity and innovation in synthetic pathways.
- Potential Applications: Beyond anti-cancer properties, research indicates that quinoxaline derivatives may possess anti-inflammatory, antimicrobial, and anti-viral activities.
In summary, 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine stands out due to its complex structure and potential therapeutic benefits. As researchers continue to explore its properties, it may pave the way for developing new medicinal treatments that address critical health challenges.